Related Experiment Videos
Intraoperative autotransfusion: advantages, disadvantages, and contraindications
1Peninsula Vascular Surgery Associates, Burlingame, CA 94010.
Seminars in Vascular Surgery
|June 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Postoperative Salvage: Technological Advance in the "Washed vs Unwashed" Blood Controversy.
Surgical technology international·2015
Endoscopic technique for subfascial perforating vein interruption.
Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery·1996
Is the "salvaged-cell syndrome" myth or reality?
American journal of surgery·1996
Value of single photon emission computerized imaging in the treatment of patients undergoing carotid endarterectomy.
Journal of vascular surgery·1996
Autologous fibrin glue: the last step in operative hemostasis.
American journal of surgery·1994
Postoperative salvage: a technological advance in the 'washed' versus 'unwashed' blood controversy.
Seminars in vascular surgery·1994
Operationalizing patient and stakeholder engagement in high-acuity trials: Lessons from IMPROVE-AD.
Seminars in vascular surgery·2026
Lost to follow-up: A narrative review of socioeconomic, psychosocial, and systemic barriers to aortic dissection surveillance.
Seminars in vascular surgery·2026
What is the best thoracic endovascular aortic repair landing zone for Type B aortic dissection?
Seminars in vascular surgery·2026
Role of illicit drug use in Type B aortic dissection and trial participation.
Seminars in vascular surgery·2026
Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.
Transplantation proceedings·2026
Hypothermic Machine Perfusion Modifies the Impact of Cold Ischemia Time on Kidney Transplant Outcomes: A Single-Center Analysis.
Transplantation proceedings·2026
Feasibility of 8 Gy TBI-Busulfan-Fludarabine Conditioning with Post-Transplant Cyclophosphamide for Pediatric High-Risk or Relapsed Acute Lymphoblastic Leukemia.
Transplantation and cellular therapy·2026